Neuropathy Inducing Medicines

active
URL
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.455
Version
20161223
PublisherOncology Nursing Society StewardDate2016-12-23T01:00:03-05:00Description

ONS measure set

Purpose

(Clinical Focus: Cancer Treatment Neuropathy Inducing Medicines),(Data Element Scope: This data element is intended to identify chemotherapeutic agents know to induce peripheral neuropathy in order to identify those people needing assessment for this toxicity in the post-treatment period. Using the Quality Data Model, this data element would map to the Assessment category.),(Inclusion Criteria: Taxane, Vinca alkaloid or Platinum-based drugs),(Exclusion Criteria: Treatments not used for breast cancer that have a side effect of Neuropathy.)

Expansion
<<>>>
CodeDisplaySystem
309311http://www.nlm.nih.gov/research/umls/rxnorm
245839http://www.nlm.nih.gov/research/umls/rxnorm
1093280http://www.nlm.nih.gov/research/umls/rxnorm
346209http://www.nlm.nih.gov/research/umls/rxnorm
313949http://www.nlm.nih.gov/research/umls/rxnorm
239178http://www.nlm.nih.gov/research/umls/rxnorm
376433http://www.nlm.nih.gov/research/umls/rxnorm
1663181http://www.nlm.nih.gov/research/umls/rxnorm
377037http://www.nlm.nih.gov/research/umls/rxnorm
376888http://www.nlm.nih.gov/research/umls/rxnorm
894899http://www.nlm.nih.gov/research/umls/rxnorm
1376083http://www.nlm.nih.gov/research/umls/rxnorm
894900http://www.nlm.nih.gov/research/umls/rxnorm
1304995http://www.nlm.nih.gov/research/umls/rxnorm
894892http://www.nlm.nih.gov/research/umls/rxnorm
1304992http://www.nlm.nih.gov/research/umls/rxnorm
57954http://www.nlm.nih.gov/research/umls/rxnorm
330562http://www.nlm.nih.gov/research/umls/rxnorm
1101769http://www.nlm.nih.gov/research/umls/rxnorm
333566http://www.nlm.nih.gov/research/umls/rxnorm